Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT07003737 · RECRUITING
Trial details
- NCT number
- NCT07003737
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-05
- Primary completion
- 2027-02-05
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.